Catholic University of Porto, Faculty of Biotechnology, Porto, Portugal.
celiaamsfcosta@gmail.com
Poster Presented at 6th World Congress on Targeting Microbiota, October 28th to 30th , 2018, Porto, Portugal.
Introduction
The human gut microbiota has become increasingly relevant when studying human health and disease due to its connection with the immune system and metabolism. Several factors are known to shape the microbiota composition, such as age, diet or genetic markers.
Furthermore, the gut microbiota can be actively modulated by prebiotics, which pass through the gastrointestinal tract and are then fermented by colonic bacteria, leading to the production of metabolites and to changes in the microbial population dynamics’[1].
In parallel, mushroom’s consumption has becoming more relevant in western diets. Coriolus versicolor is a mushroom known for its immunomodulatory properties but has also displayed prebiotic-like activity in previous studies[2,3].
The main goal of the present work was to evaluate the prebiotic potential of a commercial supplement of Coriolus versicolor biomass through in vitro faecal fermentations, using fresh faecal samples from five healthy donors, and to perform the subsequent analysis of changes in the bacterial population as well as concerning the production of short chain fatty acids(SCFA).
Conclusions:
-Coriolus versicolor biomass was able to induce changes in the gut microbiota with Firmicutes and C. leptum population reacting similarly to the presence of FOS and Coriolus versicolor biomass;
-The pH values decreased throughout the 48 h of fermentation thus showing that Coriolus versicolor was fermented.
-The fermentation led to the production of SFCA and sugar consumption. Glucose was consumed, and arabinose (a sugar present in mushroom) was detected. Propionic and acetic acid were detected after 12 h but lactic acid was only detected after 24 h of fermentation.
-This behaviour may open the possibility for its establishment as a prebiotic.
1. Wang, B., Yao, M. LV, L.; Ling, Z. & Li, L. 2017.The Human Microbiota in Health and Disease. Engineering, 3, 7182.
2. Cruz, A., Pimentel, L. L., Rodriguez-Alcala, L.M., Fernandes, T. & Pintada, M. 2016. Health Benefits of Edible Mushrooms Focused on Coriolus versicolor: A Review. Journal of Food and Nutrition Research, 4,773-781.
3. Yu, Z-T., Liu, B., Mukherjee, P. & Newburg, D.S. 2013. Trametes versicolor Extract Modifies Human Fecal Microbiota Composition in vitro. Plant Foods for Human Nutrition, 68, 107-112.
Clinical Articles
The following section outlines the clinical papers, posters and proposals that refer to the clinical use of MRL mushroom nutrition products. This information is for healthcare practitioners only and should not be provided to members of the general public.
Download PDF
Clinical articles
-
Chemical Composition of Trametes versicolor, Hericium erinaceus, and Pleurotus ostreatus Mushroom Biomass: Deciphering their Rich α-glucan Composition and Nutritional Value
Helena Araújo-Rodrigues, Manuela Amorim, Clara Sousa, Ana Sofia Salsinha, Sara Marçal, Victor de Freitas, Joao Bettencourt Relvas, Freni K. Tavaria,Manuela E. Pintado. Journal of Food Composition and Analysis 143 (2025) 107612. -
Supporting Neurologic Health with Mushroom Nutrition
Victoria Bell, Palmen Dimitrov and Tito Fernandes -
Impact of Gastrointestinal Tract on Mushroom Biomass: Deciphering Their Potential on Gut Microbiota Modulation.
Helena Araújo-Rodrigues, Ana Sofia Salsinha, João Bettencourt Relvas, Freni K. Tavaria, Manuela E. Pintado Presented at the the 10th International Human Microbiome Consortium (IHMC) Congress held on June 22-25, 2024 in Rome Italy. -
Redox Modulation of Meniere Disease by Coriolus Versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential.
Rosanna Di Paola, Rosalba Siracusa, Roberta Fusco, Marialaura Ontario, Gaetano Cammilleri, Licia Pantano, Maria Scuto, Mario Tomasello, Sestina Spanò, Angela Trovato Salinaro, Ali S. Abdelhameed, Vincenzo Ferrantelli, Antonio Arcidiacono, Tilman Fritsch, Gabriella Lupo, Anna Signorile, Luigi Maiolino, Salvatore Cuzzocrea, and Vittorio Calabrese.
Curr Neuropharmacol 2023 Dec 8. PMID: 38073105